Coston McIsaac & Partners’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
67
﹤0.01% 876
2025
Q4
$0 Hold
67
﹤0.01% 879
2025
Q3
$0 Hold
67
﹤0.01% 831
2025
Q2
$0 Buy
+67
New +$385 ﹤0.01% 806
2025
Q1
Sell
-67
Closed 806
2024
Q4
$0 Hold
67
﹤0.01% 803
2024
Q3
$1 Hold
67
﹤0.01% 720
2024
Q2
$1K Hold
67
﹤0.01% 700
2024
Q1
$1K Hold
67
﹤0.01% 691
2023
Q4
$1K Hold
67
﹤0.01% 685
2023
Q3
$1K Hold
67
﹤0.01% 691
2023
Q2
$1K Hold
67
﹤0.01% 730
2023
Q1
$1K Hold
67
﹤0.01% 759
2022
Q4
$1 Hold
67
﹤0.01% 729
2022
Q3
$0 Buy
+67
New +$1.35K ﹤0.01% 719

Other funds holding NEOG

Coston McIsaac & Partners's NEOG Position: Q1 2026 in Review

Coston McIsaac & Partners held its Neogen (NEOG) position steady in Q1 2026 at 67 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Coston McIsaac & Partners first reported a position in NEOG in Q3 2022 and has held it in 14 quarters since. The position peaked at $1K in Q2 2024. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • Coston McIsaac & Partners held 67 shares of Neogen worth $0 as of Q1 2026.
  • Coston McIsaac & Partners left its Neogen share count unchanged in Q1 2026.
  • Neogen made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q1 2026, its #876 holding.
  • Coston McIsaac & Partners first reported a position in Neogen in Q3 2022 and has held it in 14 quarters since.
  • Coston McIsaac & Partners's Neogen position peaked at $1K in Q2 2024.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.